Practical Considerations in anti-hypertensive and diuretic use in CKD
While hypertension is the second leading cause of CKD in the US, we also know that CKD can cause hypertension. Controlling blood pressure becomes more difficult as kidney disease progresses. In this module, we will cover pharmacologic and nonpharmacologic approaches to help individuals with late stage chronic kidney disease control their blood pressure.
By the end of this module, learners will be able to:
- Discuss the goal blood pressure for kidney and cardiovascular benefits and the controversies with defining target blood pressure
- Optimize blood pressure management in stage 4 and 5 CKD with use of thiazide, loop diuretics and their combination
- Recommend appropriate diuretic therapy to control volume status and the necessary monitoring parameters
- Identify patients that may benefit from addition of a mineralocorticoid receptor antagonist to improve blood pressure management in stage 4 and 5 CKD and determine an appropriate monitoring plan
Time: 45 minutes
The following planners and presenters have disclosed a financial relationship with an ineligible company:
- Katie Cardone, PharmD, BCACP, FNKF, FASN, FCCP - Grants/Research Support [Merck & Co], Consultant [Vifor, Otsuka], Honorarium [Pharmacy Times]
- Calvin Meaney, PharmD, BCPS - Speaker's Bureau [GSK], Consultant [GSK, Wolters-Kluwer (Lexicorp)]
- Wendy St. Peter, FCCP, FASN, FNKF - Consultant [GSK]
There are no conflicts of interest or financial relationships with an ineligible company that have been disclosed by the rest of the planners and presenters of this learning activity.
All relevant financial relationships have been mitigated.
In support of improving patient care, this activity is planned and implemented by The National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD). The OICPD is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians: The National Center for Interprofessional Practice and Education designates this live activity for .75 hours AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with their participation.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
Nurses: Participants will be awarded .75 contact hours of credit for attendance in this module.
Nurse Practitioners: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Pharmacists: This activity is approved for .75 contact hours. UAN: JA4008105-9999-23-018-H01-P
IPCE: This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.